全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量
470

相关文章

更多...

Multifocal Extranodal Involvement of Diffuse Large B-Cell Lymphoma

DOI: 10.1155/2013/794642

Full-Text   Cite this paper   Add to My Lib

Abstract:

Endobronchial involvement of extrapulmonary malignant tumors is uncommon and mostly associated with breast, kidney, colon, and rectum carcinomas. A 68-year-old male with a prior diagnosis of colon non-Hodgkin lymphoma (NHL) was admitted to the hospital with a complaint of cough, sputum, and dyspnea. The chest radiograph showed right hilar enlargement and opacity at the right middle zone suggestive of a mass lesion. Computed tomography of thorax revealed a right-sided mass lesion extending to thoracic wall with the destruction of the third and the fourth ribs and a right hilar mass lesion. Fiberoptic bronchoscopy was performed in order to evaluate endobronchial involvement and showed stenosis with mucosal tumor infiltration in right upper lobe bronchus. The pathological examination of bronchoscopic biopsy specimen reported diffuse large B-cell lymphoma and the patient was accepted as the endobronchial recurrence of sigmoid colon NHL. The patient is still under treatment of R-ICE (rituximab-ifosfamide-carboplatin-etoposide) chemotherapy and partial regression of pulmonary lesions was noted after 3 courses of treatment. 1. Introduction Endobronchial involvement of extrapulmonary malignant tumors is uncommon and mostly associated with breast, kidney, colon, and rectum carcinomas [1, 2]. Although the lung is a frequent site for lymphoma involvement, endobronchial metastasis of non-Hodgkin lymphoma (NHL) is extremely rare. Extranodal lymphomas originating in solid organs account for one-third of all cases of NHL. Gastrointestinal (GI) tract is the most common site of extranodal lymphomas. GI tract lymphomas occur most commonly in the stomach and colorectal NHL accounts for only 10–20% of them [3]. NHL originates from B or T lymphocytes. Mucosa-associated lymphoid tissue (MALT) and diffuse large B-cell lymphoma (DLBCL) are the most commonly observed histological subtypes in the GI tract [4]. DLBCL of the GI is an aggressive lymphoma which more commonly affects males with a median age of 50–60 years [5]. The reported 5-year survival is relatively poor, ranging between 27 and 55%. Here, we present a patient with endobronchial involvement of diffuse large B-cell lymphoma who has completely remitted sigmoid colon NHL as a primary site. 2. Case Report A 68-year-old male was admitted to the hospital with a complaint of diarrhea, abdominal pain, weight loss, and hematochezia. Ulcerated plaque-like lesions with local necrotizing areas along the 10?cm segment of sigmoid colon were detected in colonoscopy. The pathological examination of biopsy material was suggestive

References

[1]  P. P. Katsimbri, A. T. Bamias, M. E. Froudarakis, I. A. Peponis, S. H. Constantopoulos, and N. A. Pavlidis, “Endobronchial metastases secondary to solid tumors: report of eight cases and review of the literature,” Lung Cancer, vol. 28, no. 2, pp. 163–170, 2000.
[2]  T. Kiryu, H. Hoshi, E. Matsui et al., “Endotracheal/endobronchial metastases: clinicopathologic study with special reference to developmental modes,” Chest, vol. 119, no. 3, pp. 768–775, 2001.
[3]  M. Times, “Colorectal lymphoma,” Clinics in Colon and Rectal Surgery, vol. 24, no. 3, pp. 135–141, 2011.
[4]  A. Psyrri, S. Papageorgiou, and T. Economopoulos, “Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management,” Annals of Oncology, vol. 19, no. 12, pp. 1992–1999, 2008.
[5]  A. J. M. Ferreri and C. Montalbán, “Primary diffuse large B-cell lymphoma of the stomach,” Critical Reviews in Oncology/Hematology, vol. 63, no. 1, pp. 65–71, 2007.
[6]  L. Bourdeanu, R. Menon, and G. Somlo, “Diffuse large B-cell lymphoma with calf muscle localization,” Case Reports in Hematology, vol. 2011, Article ID 292494, 3 pages, 2011.
[7]  N. Neri, M. J. Nambo, and A. Avilés, “Diffuse large B-cell lymphoma primary of lung,” Hematology, vol. 16, no. 2, pp. 110–112, 2011.
[8]  H. Takahashi, N. Tomita, M. Yokoyama et al., “Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era,” Cancer, vol. 118, no. 17, pp. 4166–4172, 2012.
[9]  E. Arguder, H. C. Hasanoglu, A. Karalezli, S. Aknc, and I. Dilek, “Endobronchial involvement in non-Hodgkin lymphoma,” Journal of Bronchology & Interventional Pulmonology, vol. 19, no. 2, pp. 142–144, 2012.
[10]  A. Solomonov, T. Zuckerman, L. Goralnik, Y. Ben-Arieh, J. M. Rowe, and M. Yigla, “Non-Hodgkin's lymphoma presenting as an endobronchial tumor: report of eight cases and literature review,” American Journal of Hematology, vol. 83, no. 5, pp. 416–419, 2008.
[11]  R. Sakai, H. Kanamori, and Y. Ishigatsubo, “Long-term remission after CHOP therapy in a case of multifocal extranodal diffuse large B-cell lymphoma with t(1; 14) (p22; q32) and rearrangement of bcl-10,” The Japanese Journal of Clinical Hematology, vol. 46, no. 10, pp. 1105–1108, 2005.

Full-Text

  
  

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133